Scholarlink

Purpose <p><i>Streptococcus</i><i> pneumoniae</i> is an important human pathogen and its virulence is centered on the expression of a polysaccharide capsule. Serotyping pneumococci has clinical and epidemiological relevance. As the gold standard (Quellung reaction) is expensive and somehow laborious, alternative methodologies for timely serotyping are desirable. We aimed to evaluate IR Biotyper<sup>®</sup> (Bruker), which is based on FT-IRS, as a tool for serotyping <i>S. pneumoniae</i> by customizing a classifier focusing on PCV15 serotypes.</p> Methods <p>Initially, we evaluated the Pneumococci serogrouper (Bruker) included in the IR Biotyper<sup>®</sup> software (v.4.0) using 188 retrospective isolates of <i>S. pneumoniae</i> previously serotyped by the gold standard. Lately, these isolates were used to construct (<i>n</i> = 83) and validate (<i>n</i> = 105) the PCV15-Classifier. Overall, 1246 spectra were obtained to create a classification model using artificial neural network (ANN) machine learning in 400 cycles. Finally, prospective <i>S. pneumoniae</i> (<i>n</i> = 61), recovered from patients attended at hospitals in South Brazil, were used for a “real-life” evaluation of both classifiers.</p> Results <p>Agreement was higher when using PCV15-Classifier instead of Pneumococci serogrouper (Bruker) among both, retrospective (86.7% <i>versus</i> 68.1%; <i>p =</i> 0.0004) and prospective isolates (75.4% <i>versus</i> 70.5%; <i>p =</i> 0.54), highlighting (i) its better performance for epidemiologically relevant serotypes, such as 3, and (ii) its capacity to discriminate between serotypes of serogroup 19 (19F and 19A).</p> Conclusion <p>Altogether, our results reiterate the usefulness of IR Biotyper<sup>®</sup> for serotyping <i>S. pneumoniae</i> applying a customized classifier, which can be re-trained whenever needed, following the evolution of serotype distribution.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Evaluation of Fourier-Transform Infrared Spectroscopy with IR Biotyper® system for Streptococcus pneumoniae serotyping

  • 期刊论文

  • 发表日期：

    2025年5月21日

查看全文
  • Camila Tondolo Romero,
  • Natália Kehl Moreira,
  • Gabriela Rosa da Cunha,
  • Mariana Preussler Mott,
  • Cícero Dias,
  • Afonso Luis Barth,
  • Juliana Caierão

摘要

Purpose

Streptococcus pneumoniae is an important human pathogen and its virulence is centered on the expression of a polysaccharide capsule. Serotyping pneumococci has clinical and epidemiological relevance. As the gold standard (Quellung reaction) is expensive and somehow laborious, alternative methodologies for timely serotyping are desirable. We aimed to evaluate IR Biotyper® (Bruker), which is based on FT-IRS, as a tool for serotyping S. pneumoniae by customizing a classifier focusing on PCV15 serotypes.

Methods

Initially, we evaluated the Pneumococci serogrouper (Bruker) included in the IR Biotyper® software (v.4.0) using 188 retrospective isolates of S. pneumoniae previously serotyped by the gold standard. Lately, these isolates were used to construct (n = 83) and validate (n = 105) the PCV15-Classifier. Overall, 1246 spectra were obtained to create a classification model using artificial neural network (ANN) machine learning in 400 cycles. Finally, prospective S. pneumoniae (n = 61), recovered from patients attended at hospitals in South Brazil, were used for a “real-life” evaluation of both classifiers.

Results

Agreement was higher when using PCV15-Classifier instead of Pneumococci serogrouper (Bruker) among both, retrospective (86.7% versus 68.1%; p = 0.0004) and prospective isolates (75.4% versus 70.5%; p = 0.54), highlighting (i) its better performance for epidemiologically relevant serotypes, such as 3, and (ii) its capacity to discriminate between serotypes of serogroup 19 (19F and 19A).

Conclusion

Altogether, our results reiterate the usefulness of IR Biotyper® for serotyping S. pneumoniae applying a customized classifier, which can be re-trained whenever needed, following the evolution of serotype distribution.